Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,484.9
-44.9 (-1.78%)

 

  • STI Straits Times Index
    2,484.9
    -44.9 (-1.78%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,572.6
    -31.1 (-1.94%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,458.1
    -137.2 (-0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,368.0
    58.0 (1.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,195.4
    485.4 (2.24%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,006.2
    -143.4 (-2.78%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,314.7M
  • Value: 1,707.3M
  • Rise: 132
  • Fall: 217
  • Unch: 460

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl1.010+0.110
Moya Asia0.072+0.013
Genting Sing0.725-0.010
Singtel2.450-0.030
ThaiBev0.610-0.030
Rex Intl0.181-0.001
Arion Ent0.006-0.004
Hyphens Pharma0.585+0.020
CapitaMall Trust1.850-0.040
Spackman0.009+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

3SBIO 3SBIO
Quotes 15 Minutes Delayed. Updated at 03 Aug 2020 16:08
Last (HKD): 9.400 Change: -0.020 High: 9.610 Remarks: -
Change (%): -0.21 Low: 9.270
Open 9.480 Yesterday's Close 9.420
Buy Price 9.380 Sell Price 9.380
Buy Volume ('000) 278 Sell Volume ('000) 263.5
Cumulative Volume ('000) 21,028.617 Cumulative Value 198,674,156
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.43494 Trailing EPS (HKD) e 0.43494 NAV (HKD) b 4.2412
PE a 21.612 Trailing PE f 21.612 Price / NAV b 2.2164
Dividend (HKD) d - Cash In Hand (HKD) g 0.9275 Issued & Paid-up Shares c 2,538,530,000
Dividend Yield (%) d - Price / Cash In Hand g 10.135 Treasury Shares h -
Beta - 75 Daysi 1.333 R-Squared - 75 Days(%)i 24.98 Market Cap (M) 23,862.182
Beta - 500 Daysi 1.231 R-Squared - 500 Days (%)i 23.38 Enterprise Value (M) 25,026.052
Piotroski F Score 8 Exchange Code 1530 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 58.21 6-Month VWAP 9.555 Free Float (%) 53.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 01 Oct 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference 3SBIO HKEx 23,862.182 21.612 21.612 2.2164 -
Industry Biotechnology HKEx 58,417.509 22.881 25.668 6.6726 2.190
Local Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Local Peer WUXI BIO HKEx 217,444.670 189.153 189.153 15.2053 -
Local Peer SINO BIOPHARM HKEx 188,726.000 61.489 62.052 5.4472 0.531
Local Peer BEIGENE HKEx 151,013.200 - - 6.9281 -
Local Peer GENSCRIPT BIO HKEx 31,740.914 - - 10.6413 -
Local Peer HAOHAI BIOTEC HKEx 18,414.820 43.800 43.800 3.1308 0.740
Local Peer VIVA BIOTECH HKEx 16,191.987 53.710 53.709 8.1438 0.193
Local Peer ALPHAMAB-B HKEx 15,495.519 - - 5.7104 -
Local Peer FRONTAGE HKEx 8,374.194 57.989 57.986 4.0618 -
Local Peer ASCENTAGE-B HKEx 7,164.864 - - 7.1931 -
Local Peer KINTOR PHARMA-B HKEx 5,614.728 - - 15.1894 -
Local Peer SINOMAB BIO-B HKEx 3,552.027 - - 2.8054 -
Other Local Peers LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN H-OLD (HKEx), HAO WEN H-NEW (HKEx)
Global Peer AMGEN INC NASDAQ 143,301.751 18.274 19.633 13.4442 2.394
Global Peer GILEAD SCIENCES INC NASDAQ 87,216.346 16.193 28.299 - 3.658
Global Peer CSL ASX 125,839.680 46.904 43.441 14.5506 0.957
Global Peer VERTEX PHARMACEUTICAL NASDAQ 70,523.344 59.928 56.713 - -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 71,121.762 33.615 31.203 5.8618 -
Global Peer ILLUMINA INC NASDAQ 56,177.520 56.065 59.636 12.1203 -
Global Peer BIOGEN INC NASDAQ 43,486.998 7.385 7.337 3.8454 -
Global Peer MODERNA INC NASDAQ 28,811.858 - - 17.5588 -
Global Peer SEATTLE GENETICS INC NASDAQ 28,930.481 - - - -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,463.041 9.343 26.549 2.1412 -
Other Global Peers BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), Lonza (SGX), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), XENCOR INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), UNIQURE N.V. (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MESOBLAST LTD (ASX), VERACYTE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), NANTKWEST INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), REGENXBIO INC (NASDAQ), MACROGENICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), COMPUGEN (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), BEAM THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), OMEROS CORP (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), IMMUNOGEN INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), RAPT THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), PERSONALIS INC (NASDAQ), GERON CORP (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ARDELYX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ATHERSYS INC (NASDAQ), AGENUS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), DPHARMA (Bursa), ASPIRA WOMENS HEALTH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC